MJA
MJA

The influenza viruses

Med J Aust 2006; 185 (10): 39.
  • Alan W Hampson1,2
  • John S Mackenzie3

  • 1 Interflu Pty Ltd, Melbourne, VIC.
  • 2 School of Applied Sciences and Engineering, Monash University, Melbourne, VIC.
  • 3 Australian Biosecurity Cooperative Research Centre, Curtin University of Technology, Perth, WA.

Correspondence: interflu@bigpond.net.au

Competing interests:

Alan Hampson holds shares in CSL, and received travel assistance from Roche to attend the Lancet Asia Medical Forum on pandemic influenza, 3–4 May 2006.

  • 1. Hampson AW. Influenza virus antigens and ‘antigenic drift’. In: Potter CW, editor. Influenza. Perspectives in medical virology. 7th ed. Amsterdam: Elsevier, 2002: 49-85.
  • 2. Wood JM, Williams MS. History of inactivated influenza vaccines. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. Oxford: Blackwell Science, 1998: 317-323.
  • 3. Hirst GK. Studies of antigenic differences among strains of influenza A by means of red cell agglutination. J Exp Med 1943; 78: 407-423.
  • 4. Francis T Jr, Salk JE, Quilligan JJ Jr. Experience with vaccination against influenza in the spring of 1947. Am J Public Health 1947; 37: 1013-1016.
  • 5. Stohr K. Overview of the WHO Global Influenza Programme. Dev Biol (Basel) 2003; 115: 3-8.
  • 6. Chow A, Ma S, Ling AE, Chew SK. Influenza-associated deaths in tropical Singapore. Emerg Infect Dis 2006; 12: 114-121.
  • 7. Patterson KD. Pandemic influenza 1700–1900: a study in historical epidemiology. Totowa, NJ: Rowman & Littlefield, 1986.
  • 8. Potter CW. Chronicle of influenza pandemics. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. Oxford: Blackwell Science, 1998: 3-18.
  • 9. Pyle GF. The diffusion of influenza: patterns and paradigms. Totowa, NJ: Rowman & Littlefield, 1986.
  • 10. Beveridge WI. The chronicle of influenza epidemics. Hist Philos Life Sci 1991; 13: 223-234.
  • 11. Webster RG, Bean WJ, Gorman OT, et al. Evolution and ecology of influenza A viruses. Microbiol Rev 1992; 56: 152-179.
  • 12. Fouchier RA, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005; 79: 2814-2822.
  • 13. Webster RG, Laver WG. Antigenic variation in influenza virus. Biology and chemistry. Prog Med Virol 1971; 13: 271-338.
  • 14. Andrewes CH, Worthington G. Some new or little-known respiratory viruses. Bull World Health Organ 1959; 20: 435-443.
  • 15. Webster RG. On the origin of pandemic influenza viruses. Curr Top Microbiol Immunol 1972; 59: 75-105.
  • 16. Scholtissek C, Rohde W, Von-Hoyningen V, Rott R. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 1978; 87: 13-20.
  • 17. Webster RG, Bean WJJ. Evolution and ecology of influenza viruses: interspecies transmission. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. Oxford: Blackwell Science, 1998: 109-119.
  • 18. Taubenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. Nature 2005; 437: 889-893.
  • 19. Gibbs MJ, Gibbs AJ. Molecular virology: was the 1918 pandemic caused by a bird flu? Nature 2006; 440: E8; discussion E9-10.
  • 20. Naeve CW, Hinshaw VS, Webster RG. Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus. J Virol 1984; 51: 567-569.
  • 21. Matrosovich MN, Gambaryan AS, Teneberg S, et al. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 1997; 233: 224-234.
  • 22. Tumpey TM, Basler CF, Aguilar PV, et al. Characterization of the reconstructed 1918 spanish influenza pandemic virus. Science 2005; 310: 77-80.
  • 23. Capua I, Alexander DJ. Avian influenza: recent developments. Avian Pathol 2004; 33: 393-404.
  • 24. Swayne DE, Suarez DL. Highly pathogenic avian influenza. Rev Sci Tech 2000; 19: 463-482.
  • 25. Shortridge KF. Pandemic influenza: a zoonosis? Semin Respir Infect 1992; 7: 11-25.
  • 26. Sims LD, Domenech J, Benigno C, et al. Origin and evolution of highly pathogenic H5N1 avian influenza in Asia. Vet Rec 2005; 157: 159-164.
  • 27. World Health Organization. H5N1 influenza timeline. http://www.who.int/csr/disease/avian_influenza/timeline.pdf (accessed Oct 2006).
  • 28. World Health Organization. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. 16 October 2006. http://www.who.int/csr/disease/avian_influenza/country/cases_table_2006_10_16/en/index.html (accessed Oct 2006).
  • 29. Chen H, Smith GJ, Li KS, et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci U S A 2006; 103: 2845-2850.
  • 30. World Health Organization Global Influenza Program Surveillance Network. Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis 2005; 11: 1515-1521.
  • 31. Smith GJ, Naipospos TS, Nguyen TD, et al. Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. Virology 2006; 350: 258-268.
  • 32. Rimmelzwaan GF, van Riel D, Baars M, et al. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol 2006; 168: 176-183.
  • 33. Shinya K, Ebina M, Yamada S, et al. Avian flu: influenza virus receptors in the human airway. Nature 2006; 440: 435-436.
  • 34. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353: 1374-1385.
  • 35. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004; 363: 617-619.
  • 36. Uiprasertkul M, Puthavathana P, Sangsiriwut K, et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis 2005; 11: 1036-1041.
  • 37. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis 2003; 37: 1094-1101.
  • 38. Bean B, Moore BM, Sterner B, et al. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982; 146: 47-51.
  • 39. Bell DM. Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis 2006; 12: 81-87.
  • 40. Knight V, Gilbert BE, Wilson SZ. Airborne transmission of virus infections. In: Fields B, Martin MA, Kamely D, editors. Banbury report 22: genetically altered viruses and the environment. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1985: 73-94.
  • 41. Gerdil C. The annual production cycle for influenza vaccine. Vaccine 2003; 21: 1776-1779.
  • 42. Epstein SL. Prior H1N1 influenza infection and susceptibility of Cleveland family study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 2006; 193: 49-53.
  • 43. Harvey R, Martin AC, Zambon M, Barclay WS. Restrictions to the adaptation of influenza A virus H5 hemagglutinin to the human host. J Virol 2004; 78: 502-507.
  • 44. Maines TR, Chen LM, Matsuoka Y, et al. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci U S A 2006; 103: 12121-12126.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article